Stonvex publishes market data and research only. Not investment advice. Not a registered investment advisor. Read disclaimer.

TMDX

Live52w low +4.9%

Core line items from TMDX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

Entity: TransMedics Group, Inc.·Source: SEC EDGAR companyfacts

Metric	Annual 2021 2021-12-31	Annual 2020 2020-12-31	Annual 2019 2019-12-28	Annual 2018 2018-12-29
Revenue	$31.39M	$28.36M	$25.84M	$14.66M
Operating Income	$-39.43M	$-26.38M	$-29.60M	$-20.24M
Net Income	$-44.22M	$-28.75M	$-33.55M	$-23.76M
EPS (Diluted)	$-1.60	$-1.16	Not available	Not available
Total Assets	$134.89M	$152.03M	$105.30M	$42.16M
Total Liabilities	$67.04M	$48.13M	$50.65M	$47.88M
Cash & Equivalents	$25.58M	$24.58M	$20.09M	$20.24M
Free Cash Flow OCF − CapEx	$-32.38M	$-30.72M	$-32.45M	$-26.40M
Shares Outstanding	27.79M	27.18M	Not available	Not available

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.

Core line items from TMDX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.

52w low +4.9%

Entity: TransMedics Group, Inc.·Source: SEC EDGAR companyfacts

Metric	Annual 2021 2021-12-31	Annual 2020 2020-12-31	Annual 2019 2019-12-28	Annual 2018 2018-12-29
Revenue	$31.39M	$28.36M	$25.84M	$14.66M
Operating Income	$-39.43M	$-26.38M	$-29.60M	$-20.24M
Net Income	$-44.22M	$-28.75M	$-33.55M	$-23.76M
EPS (Diluted)	$-1.60	$-1.16	Not available	Not available
Total Assets	$134.89M	$152.03M	$105.30M	$42.16M
Total Liabilities	$67.04M	$48.13M	$50.65M	$47.88M
Cash & Equivalents	$25.58M	$24.58M	$20.09M	$20.24M
Free Cash Flow OCF − CapEx	$-32.38M	$-30.72M	$-32.45M	$-26.40M
Shares Outstanding	27.79M	27.18M	Not available	Not available

Financial data is sourced from public SEC filings where available. Some metrics may be unavailable without premium market data.